Consolidation

Altasciences acquires Alliance Contract Pharma

12-Mar-2020 By Jenni Spinner

The contract research organization has purchased Alliance Contract Pharma, a small-molecule contract manufacturing and analytical firm.

Evolution Research Group acquires Richmond Behavioral Associates

10-Mar-2020 By Jenni Spinner

The acquired company specializes in conducting clinical trials for depression, anxiety, bipolar disorder and other central nervous system conditions.

PCI acquires Bellwyck Pharma Services

17-Feb-2020 By Jenni Spinner

The purchase follows PCI’s plans to expand its clinical trial services globally, including in North America and Europe.

Three companies combine to form consulting CRO

13-Feb-2020 By Vassia Barba

Aiming to support drug developers in issues related to market insights, engagement, and access, Synaptiq enters the market backed by three consultancy agencies.

CRO ‘adding expertise’ to respond to the evolution of biometrics

06-Feb-2020 By Vassia Barba

Acquisition of Clindata’s human health biometrics division is expected to increase Synteract’s geographical footprint along with the adaptability of its biometrics services solutions.

CROs partner on joint discovery platform to accelerate R&D projects

04-Feb-2020 By Vassia Barba

Leveraging Eurofins’ pharmacology, in-vitro models and ADME capabilities, PharmaResources aims to accelerate drug discovery for its clients in small molecule drug R&D.

Bellicum offloads cell therapy plant in switch to outsourced production

28-Jan-2020 By Nick Taylor

Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.

WCG continues acquisitive streak with biostatistical consultancy buyout

23-Jan-2020 By Ben Hargreaves

WCG adds to its portfolio of solutions for clinical trial sponsors by acquiring Statistics Collaborative.

Covance guns for more late-phase contract wins to drive growth

21-Jan-2020 By Nick Taylor

Covance wants to translate its success at winning early-phase trials into more late-phase business.

Alcami sells Dutch API facility to MercachemSyncom

14-Jan-2020 By Ben Hargreaves

Alcami downsizes in Europe through the sale of its API facility to MercachemSyncom, as it expands its presence in North America.

CRO Veristat buys TCTC Group to expand in Europe

13-Jan-2020 By Nick Taylor

Veristat buys The Clinical Trial Company to establish presence in the European contract research sector.

Bristol-Myers offloads manufacturing plant to Catalent

13-Jan-2020 By Nick Taylor

Catalent buys Italian manufacturing and packaging plant from Bristol-Myers Squibb, adding oral solid, biologics and sterile product capacity.

Charles River closes $380m HemaCare cell therapy takeover

07-Jan-2020 By Nick Taylor

Charles River Laboratories closes $380m takeover of cell therapy specialist HemaCare to expand in fast-growing sector.

Five stories that grabbed readers’ attention in 2019

11-Dec-2019 By Ben Hargreaves

As we come to the close of 2019, Outsourcing-Pharma highlights the stories that made waves within our readership during the course of the year.

BASi completes PCRS takeover, continuing deal-driven expansion

10-Dec-2019 By Nick Taylor

BASi buys PCRS, adding surgical and medical device contract services to growing portfolio.